Cargando…
Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway
Osteosarcoma is the most common type of malignant bone cancer and results in cancer-related deaths among adolescents. Alantolactone (ALT) demonstrates antitumor properties in various diseases; however, its potential role in osteosarcoma is relatively unclear. The aim of the present study was to eval...
Autores principales: | Zhang, Yong, Weng, Qiuyan, Han, Jinming, Chen, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947914/ https://www.ncbi.nlm.nih.gov/pubmed/31974628 http://dx.doi.org/10.3892/mmr.2019.10882 |
Ejemplares similares
-
Oroxylin A attenuates IL-1β-induced inflammatory reaction via inhibiting the activation of the ERK and PI3K/AKT signaling pathways in osteoarthritis chondrocytes
por: Zhang, Yong, et al.
Publicado: (2021) -
Alantolactone reduced neuron injury via activating PI3K/Akt signaling pathway after subarachnoid hemorrhage in rats
por: Zhou, Feng, et al.
Publicado: (2022) -
Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
por: Mickymaray, Suresh, et al.
Publicado: (2021) -
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway
por: Da, Wacili, et al.
Publicado: (2021) -
Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways
por: Yang, Chunmei, et al.
Publicado: (2020)